Sickle Cell Disease Comprehensive Care Act
Summary
What This Bill Does
The Sickle Cell Disease Comprehensive Care Act amends Medicaid's health home option. Beginning January 1, 2026, CMS may approve state plan amendments designed primarily for Medicaid-eligible individuals with sickle cell disease. States with approved sickle cell disease-focused health homes must ensure dental and vision services for enrolled individuals regardless of comparability rules or whether the state otherwise offers those services to other Medicaid beneficiaries. Each state must report by the last day of the eighth fiscal quarter after the state plan amendment takes effect on care quality, access, and total health-care expenditures for enrolled sickle cell patients, using measures specified by the Secretary. CMS must publish best practices by June 30, 2026, based on clinical practice guidelines and consultation with sickle cell providers and patient advocacy organizations. The bill defines eligible individuals as Medicaid enrollees or waiver participants with sickle cell disease, whether or not they previously used another health home.
Who Benefits and How
Medicaid beneficiaries with sickle cell disease benefit from dedicated health homes and required dental and vision services. State Medicaid programs benefit from authority to design sickle cell disease-focused state plan amendments beginning January 1, 2026. Sickle cell disease providers benefit from CMS best practices based on clinical guidelines and provider consultation. Patient advocacy organizations benefit because CMS must consult advocates when developing implementation best practices.
Who Bears the Burden and How
State Medicaid programs must cover dental and vision services for enrolled sickle cell health home patients and submit reports by the eighth fiscal quarter. CMS Medicaid staff must approve state plan amendments, specify quality-access-cost measures, and publish best practices by June 30, 2026. Federal taxpayers bear Medicaid matching costs for expanded health home services and required dental and vision coverage. Medicaid managed care plans may need to coordinate additional dental, vision, and comprehensive-care services for enrolled patients.
Key Provisions
- Expands Medicaid health homes to eligible individuals with sickle cell disease beginning January 1, 2026.
- Requires dental and vision services for sickle cell disease health home enrollees.
- Requires state reports on quality, access, and expenditures by the eighth fiscal quarter.
- Directs CMS to publish best practices by June 30, 2026 after consulting providers and patient advocates.
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
Lets state Medicaid programs create sickle cell disease-focused health homes beginning January 1, 2026, requires dental and vision services for enrolled individuals, requires state reporting by the eighth fiscal quarter, and requires CMS best practices by June 30, 2026.
Key Policy Areas
Medicaid, Sickle Cell Disease, Health Homes
Primary Purpose
Lets state Medicaid programs create sickle cell disease-focused health homes beginning January 1, 2026, requires dental and vision services for enrolled individuals, requires state reporting by the eighth fiscal quarter, and requires CMS best practices by June 30, 2026.
Policy Domains
Resolution provisions
Identified Gains
- Medicaid beneficiaries with sickle cell disease
- State Medicaid programs
- Sickle cell disease providers
- Patient advocacy organizations
Identified Costs
- State Medicaid programs
- CMS Medicaid staff
- Federal taxpayers
- Medicaid managed care plans
Sponsors
Legislative Progress
In CommitteeMr. Dunn of Florida (for himself, Mr. Davis of Illinois, …
Referred to the House Committee on Energy and Commerce.
Introduced in House
Stakeholder Effects
cui bono?How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.
Medicaid beneficiaries with sickle cell disease
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology